You are here

News

University of Guelph biologist Paul D.N. Hebert awarded the 2018 Dr. A.H. Heineken Prize for Environmental Sciences

Tuesday, April 24, 2018

On April 24, 2018, the Royal Netherlands Academy of Arts and Sciences announced that they have awarded the 2018 Dr. A.H. Heineken Prize for Environmental Sciences to University of Guelph biologist Paul D.N. Hebert.  The Research Chair in Molecular Biodiversity at the University of Guelph, Dr. Hebert is receiving the Heineken Prize for his “pivotal contribution to developing a genetic barcode capable of classifying every biological species on Earth.” 

Notice of Upcoming Funding Opportunity: 2018 Large-Scale Applied Research Project Competition: Genomics Solutions for Agriculture, Agri-food, Fisheries and Aquaculture

Tuesday, April 10, 2018

Genome Canada is pleased to advise the research community of an upcoming funding opportunity – the 2018 Large-Scale Applied Research Project Competition: Genomics Solutions for Agriculture, Agri-food, Fisheries and Aquaculture. This Competition is anticipated to be formally launched in June 2018 with detailed guidelines and application forms available at that time.  Genome Canada is in discussion with other organizations as potential partners for this competition.

New Vice-President, Corporate Services and Chief Financial Officer at Genome Canada

Tuesday, April 3, 2018

Genome Canada is delighted to welcome Paul St George to the position of Vice President, Corporate Services and Chief Financial Officer, effective today. 
 
He has a wealth of senior leadership experience with over twenty years of managing strategic and financial affairs. Most recently he was Vice-President, Finance and CFO at Health Sciences North (HSN) in Sudbury, Ontario, which includes the Health Sciences North Research Institute. 

Funding opportunity: Research Catalyst Network to expedite collaboration between basic and clinician scientists in functional studies of novel rare disease genes

Monday, March 26, 2018

Genome Canada has partnered with the Canadian Institutes of Health Research (CIHR) to launch a funding opportunity to support a national network that will help maintain Canada’s leadership in enabling clinical geneticists who are identifying rare disease gene mutations to collaborate with model organism researchers with expertise in the cognate gene’s function, and to develop the capacity to study genes for which no suitable models can be identified in Canada with other countries with similar

Pages